When you ask “Who makes Saxenda?”, the answer depends on whether you’re referring to the original drug or the generic version:
1. The Branded Drug – Saxenda
- Manufacturer: The original Saxenda® (containing liraglutide) is developed, manufactured, and marketed by Novo Nordisk, a Danish multinational pharmaceutical company. (MIMS, Clinical Trials Arena, Wikipedia)
- Data from MIMS Thailand also confirms Novo Nordisk’s role as the manufacturer for Saxenda. (MIMS)
2. The Generic Version (Newly Approved in the U.S.)
- In August 2025, the U.S. Food and Drug Administration (FDA) approved the first generic version of Saxenda (liraglutide injection). This generic is developed and launched by Teva Pharmaceuticals. (Reuters, ir.tevapharm.com, BioSpace, Fierce Pharma)
- Teva is now the first to offer a generic GLP‑1 agonist specifically indicated for weight loss in the U.S. (Reuters, Investors.com, ir.tevapharm.com, Pharmaceutical Technology, BioSpace)
Summary Table
| Drug | Manufacturer |
|---|---|
| Branded Saxenda® | Novo Nordisk |
| Generic liraglutide (Saxenda equivalent) | Teva Pharmaceuticals (in the U.S., as of August 2025) |
So in short:
- Novo Nordisk originally manufactures and markets Saxenda under its brand.
- As of August 2025, Teva Pharmaceuticals holds the FDA-approved generic version of Saxenda in the U.S.
If you’re interested, I can also share more context on Saxenda’s approvals, its global availability, or how the market for generic weight-loss drugs is evolving.
